Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes

Completed · Early Phase 1

Conditions studied: Cystic Fibrosis, Cystic Fibrosis Related Diabetes

In brief

This project is designed to begin to characterize the abnormalities of glucagon secretion in subjects with cystic fibrosis related diabetes along the spectrum of glucose tolerance. Cystic fibrosis patients with normal glucose tolerance as well as cystic fibrosis related diabetes as well as control subjects will undergo an oral glucose tolerance test, mixed meal tolerance test, and one step hypoglycemic clamp. Cystic fibrosis patients will then return 12 months later to undergo repeat mixed meal tolerance test and hypoglycemic clamp test.

Key facts

Study ID
NCT02398383
Run by
Yale University
People needed
7
Starts
2015-03-01
Expected to finish
2017-06-22
Last updated by the study team
2020-06-26

Who can join

Age: 12 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.